Tempest Therapeutics Inc TPST released new and updated results from the planned data analysis of an ongoing Phase 1b/2 study of TPST-1120 in the first-line treatment of patients with unresectable or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results